Main variables;Fields of operation;Total Companies that perform R+D in Biotechnology;Total 2019;1,399 Companies that perform R+D in Biotechnology;Companies;1,198 Companies that perform R+D in Biotechnology;P.A.;122 Companies that perform R+D in Biotechnology;Higher Education;66 Companies that perform R+D in Biotechnology;PNPI;13 %Companies according to biotechnology used: Genetic code;Total 2019;40.8 %Companies according to biotechnology used: Genetic code;Companies;33.3 %Companies according to biotechnology used: Genetic code;P.A.;88.5 %Companies according to biotechnology used: Genetic code;Higher Education;87.9 %Companies according to biotechnology used: Genetic code;PNPI;38.5 %Companies according to biotechnology used: Functional Companies;Total 2019;46.7 %Companies according to biotechnology used: Functional Companies;Companies;39.8 %Companies according to biotechnology used: Functional Companies;P.A.;88.5 %Companies according to biotechnology used: Functional Companies;Higher Education;92.4 %Companies according to biotechnology used: Functional Companies;PNPI;53.8 %Companies according to biotechnology used: Cellular and tissue culturing and engineering;Total 2019;31.5 %Companies according to biotechnology used: Cellular and tissue culturing and engineering;Companies;24.2 %Companies according to biotechnology used: Cellular and tissue culturing and engineering;P.A.;73.0 %Companies according to biotechnology used: Cellular and tissue culturing and engineering;Higher Education;83.3 %Companies according to biotechnology used: Cellular and tissue culturing and engineering;PNPI;53.8 %Companies according to biotechnology used: Bioprocesses;Total 2019;52.4 %Companies according to biotechnology used: Bioprocesses;Companies;49.6 %Companies according to biotechnology used: Bioprocesses;P.A.;59.0 %Companies according to biotechnology used: Bioprocesses;Higher Education;92.4 %Companies according to biotechnology used: Bioprocesses;PNPI;46.2 %Companies according to biotechnology used: Sub-cellular organisms;Total 2019;14.4 %Companies according to biotechnology used: Sub-cellular organisms;Companies;6.7 %Companies according to biotechnology used: Sub-cellular organisms;P.A.;56.6 %Companies according to biotechnology used: Sub-cellular organisms;Higher Education;72.7 %Companies according to biotechnology used: Sub-cellular organisms;PNPI;38.5 %Companies according to biotechnology used: Bio-computing;Total 2019;30.8 %Companies according to biotechnology used: Bio-computing;Companies;23.9 %Companies according to biotechnology used: Bio-computing;P.A.;71.3 %Companies according to biotechnology used: Bio-computing;Higher Education;84.8 %Companies according to biotechnology used: Bio-computing;PNPI;15.4 %Companies according to biotechnology used: Nanobiotechnology;Total 2019;17.4 %Companies according to biotechnology used: Nanobiotechnology;Companies;11.2 %Companies according to biotechnology used: Nanobiotechnology;P.A.;50.8 %Companies according to biotechnology used: Nanobiotechnology;Higher Education;71.2 %Companies according to biotechnology used: Nanobiotechnology;PNPI;7.7 %Companies according to biotechnology used: Other;Total 2019;13.9 %Companies according to biotechnology used: Other;Companies;14.6 %Companies according to biotechnology used: Other;P.A.;7.4 %Companies according to biotechnology used: Other;Higher Education;15.2 %Companies according to biotechnology used: Other;PNPI;7.7 Companies in which biotechnology activities are: Main and/or exclusive;Total 2019;685 Companies in which biotechnology activities are: Main and/or exclusive;Companies;644 Companies in which biotechnology activities are: Main and/or exclusive;P.A.;33 Companies in which biotechnology activities are: Main and/or exclusive;Higher Education;2 Companies in which biotechnology activities are: Main and/or exclusive;PNPI;6 Companies in which biotechnology activities are: A secondary line of business;Total 2019;253 Companies in which biotechnology activities are: A secondary line of business;Companies;171 Companies in which biotechnology activities are: A secondary line of business;P.A.;37 Companies in which biotechnology activities are: A secondary line of business;Higher Education;43 Companies in which biotechnology activities are: A secondary line of business;PNPI;2 Companies in which biotechnology activities are: A tool necessary for production;Total 2019;461 Companies in which biotechnology activities are: A tool necessary for production;Companies;383 Companies in which biotechnology activities are: A tool necessary for production;P.A.;52 Companies in which biotechnology activities are: A tool necessary for production;Higher Education;21 Companies in which biotechnology activities are: A tool necessary for production;PNPI;5 %Companies by field(s) of ultimate application of biotechnology use: Human health;Total 2019;52 %Companies by field(s) of ultimate application of biotechnology use: Human health;Companies;47 %Companies by field(s) of ultimate application of biotechnology use: Human health;P.A.;77 %Companies by field(s) of ultimate application of biotechnology use: Human health;Higher Education;91 %Companies by field(s) of ultimate application of biotechnology use: Human health;PNPI;62 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Total 2019;21 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Companies;19 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;P.A.;16 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;Higher Education;68 %Companies by field(s) of ultimate application of biotechnology use: Animal Health and Aquaculture;PNPI;8 %Companies by field(s) of ultimate application of biotechnology use: Food products;Total 2019;33 %Companies by field(s) of ultimate application of biotechnology use: Food products;Companies;33 %Companies by field(s) of ultimate application of biotechnology use: Food products;P.A.;19 %Companies by field(s) of ultimate application of biotechnology use: Food products;Higher Education;80 %Companies by field(s) of ultimate application of biotechnology use: Food products;PNPI;8 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Total 2019;26 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Companies;24 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;P.A.;20 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;Higher Education;71 %Companies by field(s) of ultimate application of biotechnology use: Agriculture and forest production:;PNPI;23 %Companies by field(s) of ultimate application of biotechnology use: Environment;Total 2019;18 %Companies by field(s) of ultimate application of biotechnology use: Environment;Companies;15 %Companies by field(s) of ultimate application of biotechnology use: Environment;P.A.;21 %Companies by field(s) of ultimate application of biotechnology use: Environment;Higher Education;74 %Companies by field(s) of ultimate application of biotechnology use: Environment;PNPI;15 %Companies by field(s) of ultimate application of biotechnology use: Industry;Total 2019;16 %Companies by field(s) of ultimate application of biotechnology use: Industry;Companies;13 %Companies by field(s) of ultimate application of biotechnology use: Industry;P.A.;13 %Companies by field(s) of ultimate application of biotechnology use: Industry;Higher Education;70 %Companies by field(s) of ultimate application of biotechnology use: Industry;PNPI;8 Personnel in R&D in biotechnology (no. of persons);Total 2019;43,523 Personnel in R&D in biotechnology (no. of persons);Companies;13,615 Personnel in R&D in biotechnology (no. of persons);P.A.;14,682 Personnel in R&D in biotechnology (no. of persons);Higher Education;15,063 Personnel in R&D in biotechnology (no. of persons);PNPI;163 Personnel in R&D in biotechnology (no. of persons): Researchers;Total 2019;28,702 Personnel in R&D in biotechnology (no. of persons): Researchers;Companies;7,436 Personnel in R&D in biotechnology (no. of persons): Researchers;P.A.;9,191 Personnel in R&D in biotechnology (no. of persons): Researchers;Higher Education;11,968 Personnel in R&D in biotechnology (no. of persons): Researchers;PNPI;107 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Total 2019;14,820 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Companies;6,178 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;P.A.;5,491 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;Higher Education;3,095 Personnel in R&D in biotechnology (no. of persons): Technicians and assistants;PNPI;56 Personnel in R&D in biotechnology (no. of persons): women;Total 2019;24,516 Personnel in R&D in biotechnology (no. of persons): women;Companies;7,639 Personnel in R&D in biotechnology (no. of persons): women;P.A.;9,277 Personnel in R&D in biotechnology (no. of persons): women;Higher Education;7,494 Personnel in R&D in biotechnology (no. of persons): women;PNPI;106 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Total 2019;15,356 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Companies;4,095 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;P.A.;5,444 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;Higher Education;5,753 Personnel in R&D in biotechnology (no. of persons): (women) Researchers;PNPI;64 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Total 2019;9,160 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Companies;3,544 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;P.A.;3,833 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;Higher Education;1,741 Personnel in R&D in biotechnology (no. of persons): (women) Technicians and assistants;PNPI;42 Personnel in R&D in biotechnology (FTE);Total 2019;29,655.1 Personnel in R&D in biotechnology (FTE);Companies;9,365.2 Personnel in R&D in biotechnology (FTE);P.A.;11,013.2 Personnel in R&D in biotechnology (FTE);Higher Education;9,177.3 Personnel in R&D in biotechnology (FTE);PNPI;99.4 Personnel in R&D in biotechnology (FTE): Researchers;Total 2019;19,150.3 Personnel in R&D in biotechnology (FTE): Researchers;Companies;5,410.6 Personnel in R&D in biotechnology (FTE): Researchers;P.A.;6,546.6 Personnel in R&D in biotechnology (FTE): Researchers;Higher Education;7,128.5 Personnel in R&D in biotechnology (FTE): Researchers;PNPI;64.6 Personnel in R&D in biotechnology (FTE): Technicians and assistants;Total 2019;10,504.8 Personnel in R&D in biotechnology (FTE): Technicians and assistants;Companies;3,954.6 Personnel in R&D in biotechnology (FTE): Technicians and assistants;P.A.;4,466.6 Personnel in R&D in biotechnology (FTE): Technicians and assistants;Higher Education;2,048.8 Personnel in R&D in biotechnology (FTE): Technicians and assistants;PNPI;34.8 Personnel in R&D in biotechnology (FTE): women;Total 2019;16,997.1 Personnel in R&D in biotechnology (FTE): women;Companies;5,385.8 Personnel in R&D in biotechnology (FTE): women;P.A.;6,959.9 Personnel in R&D in biotechnology (FTE): women;Higher Education;4,581.4 Personnel in R&D in biotechnology (FTE): women;PNPI;70.0 Personnel in R&D in biotechnology (FTE): (women) Researchers;Total 2019;10,349.2 Personnel in R&D in biotechnology (FTE): (women) Researchers;Companies;3,032.9 Personnel in R&D in biotechnology (FTE): (women) Researchers;P.A.;3,876.1 Personnel in R&D in biotechnology (FTE): (women) Researchers;Higher Education;3,397.2 Personnel in R&D in biotechnology (FTE): (women) Researchers;PNPI;43.0 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Total 2019;6,647.9 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Companies;2,352.9 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;P.A.;3,083.8 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;Higher Education;1,184.2 Personnel in R&D in biotechnology (FTE): (women) Technicians and assistants;PNPI;27.0 Internal expenditure on R&D (thousands of euros);Total 2019;2,040,323 Internal expenditure on R&D (thousands of euros);Companies;940,230 Internal expenditure on R&D (thousands of euros);P.A.;652,393 Internal expenditure on R&D (thousands of euros);Higher Education;442,089 Internal expenditure on R&D (thousands of euros);PNPI;5,611 1) By nature of the expense: Current expenses;Total 2019;1,899,869 1) By nature of the expense: Current expenses;Companies;871,813 1) By nature of the expense: Current expenses;P.A.;608,579 1) By nature of the expense: Current expenses;Higher Education;413,960 1) By nature of the expense: Current expenses;PNPI;5,517 1.1) Remuneration to researchers;Total 2019;776,880 1.1) Remuneration to researchers;Companies;284,936 1.1) Remuneration to researchers;P.A.;242,168 1.1) Remuneration to researchers;Higher Education;247,973 1.1) Remuneration to researchers;PNPI;1,802 1.2) Remuneration to technicians and assistants;Total 2019;333,017 1.2) Remuneration to technicians and assistants;Companies;148,254 1.2) Remuneration to technicians and assistants;P.A.;118,062 1.2) Remuneration to technicians and assistants;Higher Education;65,769 1.2) Remuneration to technicians and assistants;PNPI;931 1.3) Other current expenses;Total 2019;789,972 1.3) Other current expenses;Companies;438,623 1.3) Other current expenses;P.A.;248,348 1.3) Other current expenses;Higher Education;100,217 1.3) Other current expenses;PNPI;2,784 2) By nature of the expense: Capital expenses;Total 2019;140,454 2) By nature of the expense: Capital expenses;Companies;68,417 2) By nature of the expense: Capital expenses;P.A.;43,814 2) By nature of the expense: Capital expenses;Higher Education;28,129 2) By nature of the expense: Capital expenses;PNPI;94 2.1) Land and buildings;Total 2019;30,677 2.1) Land and buildings;Companies;11,763 2.1) Land and buildings;P.A.;11,874 2.1) Land and buildings;Higher Education;7,040 2.1) Land and buildings;PNPI;0 2.2) Equipment and instruments;Total 2019;90,306 2.2) Equipment and instruments;Companies;39,641 2.2) Equipment and instruments;P.A.;31,009 2.2) Equipment and instruments;Higher Education;19,567 2.2) Equipment and instruments;PNPI;89 2.3) Acquisition of specific R+D software;Total 2019;4,900 2.3) Acquisition of specific R+D software;Companies;2,831 2.3) Acquisition of specific R+D software;P.A.;757 2.3) Acquisition of specific R+D software;Higher Education;1,310 2.3) Acquisition of specific R+D software;PNPI;3 2.4) Otros productos de propiedad intelectual específicos para I+D;Total 2019;14,571 2.4) Otros productos de propiedad intelectual específicos para I+D;Companies;14,183 2.4) Otros productos de propiedad intelectual específicos para I+D;P.A.;173 2.4) Otros productos de propiedad intelectual específicos para I+D;Higher Education;212 2.4) Otros productos de propiedad intelectual específicos para I+D;PNPI;2 1.1) By origin of the funds: Own funds;Total 2019;742,583 1.1) By origin of the funds: Own funds;Companies;577,287 1.1) By origin of the funds: Own funds;P.A.;78,505 1.1) By origin of the funds: Own funds;Higher Education;86,280 1.1) By origin of the funds: Own funds;PNPI;511 1.2) By origin of the funds: From companies;Total 2019;268,227 1.2) By origin of the funds: From companies;Companies;142,672 1.2) By origin of the funds: From companies;P.A.;96,507 1.2) By origin of the funds: From companies;Higher Education;28,164 1.2) By origin of the funds: From companies;PNPI;884 1.3) By origin of the funds: Public Administration funds;Total 2019;783,942 1.3) By origin of the funds: Public Administration funds;Companies;102,630 1.3) By origin of the funds: Public Administration funds;P.A.;396,610 1.3) By origin of the funds: Public Administration funds;Higher Education;282,374 1.3) By origin of the funds: Public Administration funds;PNPI;2,327 1.4) By origin of the funds: From Universities;Total 2019;2,785 1.4) By origin of the funds: From Universities;Companies;457 1.4) By origin of the funds: From Universities;P.A.;1,190 1.4) By origin of the funds: From Universities;Higher Education;1,138 1.4) By origin of the funds: From Universities;PNPI;0 1.5) By origin of the funds: From non profit private institutions;Total 2019;30,232 1.5) By origin of the funds: From non profit private institutions;Companies;9,631 1.5) By origin of the funds: From non profit private institutions;P.A.;13,309 1.5) By origin of the funds: From non profit private institutions;Higher Education;5,740 1.5) By origin of the funds: From non profit private institutions;PNPI;1,553 1.6) By origin of the funds: Foreign funds;Total 2019;212,555 1.6) By origin of the funds: Foreign funds;Companies;107,553 1.6) By origin of the funds: Foreign funds;P.A.;66,273 1.6) By origin of the funds: Foreign funds;Higher Education;38,392 1.6) By origin of the funds: Foreign funds;PNPI;336 Purchase of services R & D in Biotechnology to (thousands of euros);Total 2019;133,151 Purchase of services R & D in Biotechnology to (thousands of euros);Companies;114,839 Purchase of services R & D in Biotechnology to (thousands of euros);P.A.;12,728 Purchase of services R & D in Biotechnology to (thousands of euros);Higher Education;5,216 Purchase of services R & D in Biotechnology to (thousands of euros);PNPI;368 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Total 2019;85,933 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Companies;69,258 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;P.A.;11,630 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;Higher Education;4,727 Purchase of services R & D in Biotechnology to (thousands of euros): in Spain;PNPI;318 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Total 2019;47,219 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Companies;45,581 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;P.A.;1,098 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;Higher Education;489 Purchase of services R & D in Biotechnology to (thousands of euros): Abroad;PNPI;51 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Total 2019;44.2 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Companies;41.8 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;P.A.;57.4 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;Higher Education;56.1 %Companies that consider the following obstacles as very important considering biotechnology development: Access to capital;PNPI;76.9 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Total 2019;11.3 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Companies;12.0 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;P.A.;2.5 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;Higher Education;12.1 %Companies that consider the following obstacles as very important considering biotechnology development: Access to technology / information;PNPI;23.1 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Total 2019;16.8 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Companies;13.1 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;P.A.;39.3 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;Higher Education;40.9 %Companies that consider the following obstacles as very important considering biotechnology development: Access to human resources;PNPI;30.8 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Total 2019;13.4 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Companies;10.7 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;P.A.;28.7 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;Higher Education;33.3 %Companies that consider the following obstacles as very important considering biotechnology development: Disconnection from the value chain;PNPI;23.1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Total 2019;18.1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Companies;15.1 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;P.A.;32.8 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;Higher Education;42.4 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of access to international markets;PNPI;30.8 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Total 2019;18 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Companies;16 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;P.A.;30 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;Higher Education;41 %Companies that consider the following obstacles as very important considering biotechnology development: Lack of distribution and marketing channels;PNPI;23 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Total 2019;15.2 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Companies;15.9 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;P.A.;9.0 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;Higher Education;10.6 %Companies that consider the following obstacles as very important considering biotechnology development: Acceptance / public perception;PNPI;38.5 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Total 2019;37 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Companies;37 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;P.A.;41 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;Higher Education;36 %Companies that consider the following obstacles as very important considering biotechnology development: Legal and regulatory requirements;PNPI;39 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Total 2019;51.9 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Companies;50.7 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;P.A.;57.4 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;Higher Education;63.6 %Companies that consider the following obstacles as very important considering biotechnology development: Time / cost;PNPI;53.8 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Total 2019;19.1 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Companies;19.0 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;P.A.;20.5 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;Higher Education;16.7 %Companies that consider the following obstacles as very important considering biotechnology development: Difficulty accessing patenting;PNPI;30.8 %Companies that have requested biotechnology patents in Biotechnology;Total 2019;23.7 %Companies that have requested biotechnology patents in Biotechnology;Companies;18.3 %Companies that have requested biotechnology patents in Biotechnology;P.A.;53.3 %Companies that have requested biotechnology patents in Biotechnology;Higher Education;69.7 %Companies that have requested biotechnology patents in Biotechnology;PNPI;7.7 Number of patents requested;Total 2019;1,846 Number of patents requested;Companies;643 Number of patents requested;P.A.;667 Number of patents requested;Higher Education;535 Number of patents requested;PNPI;1